BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

China National Biotech Group Institute Buys Vaccine Conjugate Technology From FinaBio


8/21/2012 10:05:12 AM

by Richard Daverman, PhD

August 20, 2012 -- The Chengdu Institute of Biological Products (CDIBP) has licensed technology for producing less-expensive conjugate vaccines from Fina Biosolutions LLC, a Maryland company that provides protein purification and bioconjugation services. CDIBP will use the technology to develop pneumococcal conjugate vaccines for the China market. CDIBP is a subsidiary of China National Biotec Group (CNBG), which is part of China National Pharmaceutical Group Corporation (Sinopharm). CDIPB will pay FinaBio an upfront fee, milestone payments and royalties. More details....



Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->